We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Sciex

SCIEX develops and sells scientific instrumentation, software, and services for the life science, clinical research, ... read more Featured Products: More products

Download Mobile App




Blood Test May Help Predict Confusion Post-Surgery

By LabMedica International staff writers
Posted on 09 Feb 2017
Print article
Image: The Triple Time-Of-Flight 5600 Mass Spectrometer (Photo courtesy of Sciex).
Image: The Triple Time-Of-Flight 5600 Mass Spectrometer (Photo courtesy of Sciex).
Many people experience an extended period of confusion when they awake after surgery and this acute confusional state, called delirium, particularly affects older adults and poses an important clinical challenge as it can lead to greater postoperative complications and may extend hospitalization.

Several biological models of delirium have been proposed and these include neuroinflammation, neurological aging, neuroendocrine stress, neurotransmitter dysregulation, oxidative stress, sleep/wake dysregulation, and network disconnectivity. The identification of a marker associated with delirium would advance our understanding of the pathophysiology of delirium and ultimately lead to new interventions that could improve patient outcomes.

Medial scientists at the Beth Israel Deaconess Medical Center enrolled 566 patients equal to or greater than 70 years old who were scheduled for major non-cardiac surgery, including total hip or knee replacement, cervical or lumbar laminectomy, abdominal aortic aneurysm repair, lower extremity vascular bypass, or colectomy. Patients received either general or spinal anesthesia. Blood samples were drawn at four time points before and after surgery from relatively healthy older adults who were undergoing major elective surgery.

The initial proteomics phase used isobaric tags for relative and absolute quantitation mass spectrometry assay to examine five sets of matched case-control plasma samples across the four time points in the discovery cohort. Relative quantitation proteomics was performed using the iTRAQ isobaric tagging system. In the biomarker validation stage, an antibody-based enzyme-linked immunosorbent assay (ELISA) was employed.

The scientists used a global proteomics approach to compare all proteins in the blood from a subset of the patients, C-reactive protein (CRP) emerged with the strongest association to postoperative delirium. In a discovery cohort of 39 matched cases, control pairs revealed that cases had higher CRP levels before the surgery and two days after, when delirium peaks. In a replication cohort of 36 different matched pairs, cases had higher CRP levels immediately after surgery and two days later.

Sarinnapha Vasunilashorn, PhD, co-first author of the study, said, “Our ability to pinpoint CRP levels as being significantly elevated before and after postoperative delirium onset establishes CRP as a risk marker, as well as a disease marker, for delirium. The findings also provide insight into what causes delirium and what puts someone at risk.” The study was published on January 15, 2017, in the journal Biological Psychiatry.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.